Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
by The Investment U Research Team
Yesterday we were reading how Microsoft (Nasdaq: MSFT) has been getting pretty testy with reporters concerning questions over it’s strategy to break into the advertising market that Google (Nasdaq: GOOG) controls.
Microsoft finds itself in an unusual position of weakness as it struggles to play catch up. The word on the street was that they are throwing themselves at trying to edge Google off its position of strength in the ad market.
This morning we may have heard the “response” from Google. Google is going to be offering it’s own operating system called Chrome. This is the core strength of Microsoft, and going after it is a direct attack from Google.
While much is being made – and will continue to be for a while – of this new software competing with Google, the reality is that Microsoft has been competing with Google for a while now in terms of online applications. It just removed the “beta” tags from its online software of gmail and suite.
Apple (Nasdaq: AAPL) has 50,000 apps on its iPhone app store – this space has been cluttered for some time now.
The question is whether Google’s timing of Chrome is specifically meant to disrupt the roll out of Windows 7 slated for later this year. By pulling customers away from what looks to be Microsoft’s next big act, Google will be obviously competing toe to toe with the software titan in Redmond.
Any missteps could come back to haunt either company.
Symbols mentioned in this article: MSFT, GOOG and AAPL.
- Yahoo! Lets Go, Google Takes Over
- Best Invention of 2008: Apple (Nasdaq: AAPL) App Store
- Microsoft’s (Nasdaq: MSFT) Miss Shouldn’t Surprise
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed